Around two-thirds of the participants (64%) were on oral hypoglycaemic drugs (OHD), 9% were on insulin therapy, 19% were on both OHD and insulin, and 9% were advised to change their lifestyle to control Diabetes Mellitus. The gene discussed is INS; the disease is diabetes mellitus.